shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > Mumbai > Mumbai News > Article > Covid 19 Maharashtra suspends vaccination for 18 44 age group

Covid-19: Maharashtra suspends vaccination for 18-44 age group

Updated on: 12 May,2021 12:00 AM IST  |  Mumbai
PTI |

Tope also revealed that the Serum Institute of India has informed the Maharashtra government that it would be able to provide 1.5 crore Covishield vaccines to the state only May 20 onwards.

Covid-19: Maharashtra suspends vaccination for 18-44 age group

A senior citizen takes Covid-19 vaccine on the first day at Radio Club, Colaba. Pic/Bipin Kokate

Due to the acute shortage of Covid-19 vaccines in Maharashtra, the state government on Wednesday decided to temporarily suspend its drive to vaccinate people in the age group of 18 to 44 and divert the available stock of doses for the above-45 age group, Health Minister Rajesh Tope said.


This decision was taken during the state cabinet meeting. The minister also revealed that the Serum Institute of India (SII) has informed the Maharashtra government that it would be able to provide 1.5 crore Covishield vaccines to the state only May 20 onwards.


Also Read: Maharashtra: CVC orders probe in 'mega-corruption' in Remdesivir supplies


"There is no sufficient supply of vaccine vials by the Centre for inoculation of above-45 age group people. Hence, the state cabinet decided to divert the stock, purchased for the 18-44 age group, for the above-45 age group. Therefore, we are suspending the inoculation of 18-44 age group for some period," Tope said.

While Covishield vaccine is manufactured by Pune-based SII, Covaxin is produced by Bharat Biotech.

"Adar Poonawalla of SII has informed Chief Minister Uddhav Thackeray of his ability to supply around 1.5 crore vials of Covishield from May 20 onwards. Once we receive the supply, we will resume the vaccination of 18-44 age group," the minister said.

On Tuesday, Tope had alleged that the Union government was not fulfilling its responsibility to provide adequate number of vaccine doses to states.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK